A chemical screen identifies BET bromodomain inhibitors as inducers of an activated skin keratinocyte state that promotes the wound-healing capabilities of these cells. The study implicates epigenetic modifiers as potential targets for non-healing, chronic wounds.
References
Biggs, L. C., Kim, C. S., Miroshnikova, Y. A. & Wickström, S. A. J. Invest. Dermatol. 140, 284–290 (2020).
Eming, S. A., Martin, P. & Tomic-Canic, M. Sci. Transl. Med. 6, 265sr6 (2014).
Lewis, C. J., Stevenson, A., Fear, M. W. & Wood, F. M. Wound Repair Regen. 28, 710–718 (2020).
Schutzius, G. et al. Nat. Chem. Biol. https://doi.org/10.1038/s41589-020-00716-z (2020).
Pastar, I. et al. Adv. Wound Care (New Rochelle) 3, 445–464 (2014).
Muller, S., Filippakopoulos, P. & Knapp, S. Expert Rev. Mol. Med. 13, e29 (2011).
Pérez-Salvia, M. & Esteller, M. Epigenetics 12, 323–339 (2017).
Pervaiz, M., Mishra, P. & Günther, S. Chem. Rec. 18, 1808–1817 (2018).
Miroshnikova, Y. A., Cohen, I., Ezhkova, E. & Wickström, S. A. Curr. Opin. Genet. Dev. 55, 46–51 (2019).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Ylivinkka, I., Wickström, S.A. BETting against wound healing. Nat Chem Biol 17, 233–235 (2021). https://doi.org/10.1038/s41589-020-00709-y
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41589-020-00709-y
- Springer Nature America, Inc.